Microbial culturing is a process of cultivation and growth of microorganisms in a specified culture medium under controlled laboratory conditions. It is a key diagnostic method in microbiology used to determine the cause of infectious diseases by culturing the pathogen in a pre-set medium. One of the most important reasons for culturing microorganisms such as bacteria and fungi in vitro is for diagnosis of infectious diseases. Bacteria need to be cultured in order to obtain antigens from development of serological assays or vaccines. Microorganisms are required to have effective metabolism along with high productivity to achieve an economical production process. Microorganisms are categorized into two types viz. prokaryotes and eukaryotes. Prokaryotes are organisms that lack membrane-bound nucleus and other cell organelles. These are single-cell bacteria. Eukaryotes are organisms with membrane-bound nucleus and other cell organelles. Eukaryotes can be unicellular or multicellular organisms such as fungi, plants, and animals. Culture mediums used for cultivating eukaryotic organisms are referred to as eukaryotic microbiological culture mediums.
Eukaryotic cell culture mediums comprise yeast culture mediums and certain other culture mediums such as algae (eukaryotic) culture mediums. Presently, yeast culture mediums that are primarily available in liquid and powder forms are specifically formulated and prepared for use in propagating and/or maintaining yeast strains. A wide range of yeast culture mediums made by a large number of manufacturers and suppliers are available across the globe. Key yeast culture mediums include candida ident agar modified by Sigma-Aldrich and PichiaPink Media, CSM media, YPD broth, and yeast nitrogen base made by Thermo Fisher Scientific. Other eukaryotic culture mediums include algae (certain forms of algae are eukaryotic) culture mediums such as Gibco TAP growth media, which are optimized for Chlamydomonas reinhardtii by Thermo Fisher Scientific.
The eukaryotic cell culture mediums market is anticipated to witness strong growth due to wide range of applications of these media in various fields such as food & veterinary pharmaceutical, and biotechnology. Increase in the prevalence of infectious diseases and rise in the demand for antibiotics are expected to boost the market during the forecast period. However, high costs associated with these media and the entire fermentation process are likely to hamper the eukaryotic cell culture mediums market in the next few years. Moreover, mutations in microorganisms over a period of time and dearth of skilled professionals are major restraints for the market.
The global eukaryotic cell culture mediums market can be segmented based on type, application, end-user, and region. Based on type, the culture mediums market has been segregated into liquid medium and solid medium. Currently, different types of media such as DMEM, RPMI-1640, McCoy's 5A medium, and BG-11 are used for growth and cultivation of different types of eukaryotic cells. Solid media such as YPD agar are used for cultivation of yeast cells. Based on application, the eukaryotic cell culture mediums market has been segmented into growth medium used for cultivation and growth of yeast & mold cells, human cells, and animal cells. Based on end-user, the culture mediums market has been divided into research laboratories, educational institutions, hospitals, pathology labs, and others.
In terms of geography, the global eukaryotic cell culture mediums market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East &Africa. North America accounted for a leading share of the global eukaryotic cell culture mediums market in 2016 followed by Europe. These regions are anticipated to dominate the global market during the forecast period as well, due to increasing government funding for research in life sciences and highly sophisticated infrastructure available for microbiological research and development in these regions. Moreover, with the increasing demand for antibiotics in North America and Europe, demand for culture mediums is increasing. The Asia Pacific market is also likely to witness significant growth culture mediums during the forecast period, owing to rise in disposable income, increase in health care infrastructure, and high prevalence of infectious diseases in the region.
Key players in the global eukaryotic cell culture mediums market include Becton, Dickinson & Company, Bio-Rad Laboratories, Eiken Chemical Co., Ltd., Hi-Media Laboratories, Sigma-Aldrich Co. LLC (Merck Millipore), and Thermo Fisher Scientific, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.